RG
TNDM icon

Redmile Group’s Tandem Diabetes Care TNDM Stock Holding History

Redmile Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-187,460
Closed -$11.1M – 74
2022
Q2 		$11.1M Sell
187,460
-83,758
-31% -$6.88M 0.42% 48
2022
Q1 		$31.5M Buy
+271,218
New +$31.7M 0.98% 28
2020
Q2 		– Sell
-881,266
Closed -$56.7M – 86
2020
Q1 		$56.7M Sell
881,266
-290,966
-25% -$20.4M 1.59% 20
2019
Q4 		$69.9M Buy
1,172,232
+11,831
+1% +$730K 1.67% 21
2019
Q3 		$68.4M Sell
1,160,401
-5,631
-0.5% -$359K 2.29% 13
2019
Q2 		$75.2M Buy
1,166,032
+310,100
+36% +$20M 2.13% 14
2019
Q1 		$54.4M Sell
855,932
-183,818
-18% -$9.66M 1.59% 20
2018
Q4 		$39.5M Sell
1,039,750
-29,920
-3% -$1.06M 1.59% 23
2018
Q3 		$45.8M Buy
+1,069,670
New +$37.4M 1.41% 24

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Redmile Group's TNDM Position: Q3 2022 in Review

Redmile Group sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 187,460 shares — an estimated $11.1M sold.

Redmile Group first reported a position in TNDM in Q3 2018 and held it in 9 quarters. The position peaked at $75.2M in Q2 2019. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Redmile Group reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Redmile Group sold 187,460 Tandem Diabetes Care shares in Q3 2022, an estimated $11.1M.
  • Redmile Group first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 9 quarters.
  • Redmile Group's Tandem Diabetes Care position peaked at $75.2M in Q2 2019.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Redmile Group's 13F filing for Q3 2022, filed 14 Nov 2022.